231 related articles for article (PubMed ID: 4398545)
1. [Clinical evaluation of a new antihistaminic: HS-592].
von Bernath Z
Prensa Med Argent; 1971 Jul; 58(21):1071-5. PubMed ID: 4398545
[No Abstract] [Full Text] [Related]
2. [Clinical experience with HS-592 (a new antihistaminic) for so-called allergic rhinitis].
Baba S; Oashi M; Seno Y; Maruo T
Penn Dent J (Phila); 1970 Mar; 73(2):319-22. PubMed ID: 4192065
[No Abstract] [Full Text] [Related]
3. Clinical evaluation of antihistamine, HS-592, in seasonal and perennial allergic rhinitis.
Pan A
Ann Allergy; 1970 Feb; 28(2):69-72. PubMed ID: 4403482
[No Abstract] [Full Text] [Related]
4. [Clinical trial of a new antihistaminic for allergic rhinitis].
Axelsson A
Lakartidningen; 1970 Jul; 67(27):3105-8. PubMed ID: 4393901
[No Abstract] [Full Text] [Related]
5. [A new antihistaminic in the treatment of allergic diseases].
Basomba A; Oehling A
Rev Clin Esp; 1968 Jun; 109(5):417-22. PubMed ID: 4391259
[No Abstract] [Full Text] [Related]
6. [Clinical evaluation of the antihistaminic activity of a new antihistaminic product with selective and non hypnotic action (HS 592)].
De Caro L; Rizzo SC
Folia Allergol (Roma); 1969; 16(3):234-48. PubMed ID: 4397213
[No Abstract] [Full Text] [Related]
7. Clinical trials of a new antihistaminic HS 592.
Safwat FM
Rev Laryngol Otol Rhinol (Bord); 1972; 93(11):743-6. PubMed ID: 4146016
[No Abstract] [Full Text] [Related]
8. [Preliminary clinical experience with a new drug with antihistaminic action (HS 592)].
Corrado Negrini A; Dolcino G
Arch Maragliano Patol Clin; 1967; 23(6):733-47. PubMed ID: 4389860
[No Abstract] [Full Text] [Related]
9. [Clinical and allergological evaluation of Tavegil (HS-592), a new antihistaminic drug].
Bogdaszewska-Czabanowska ; Starzycki Z
Przegl Dermatol; 1969; 56(5):659-65. PubMed ID: 4391299
[No Abstract] [Full Text] [Related]
10. [The rebirth of the H1-antagonists].
Sabbah A
Allerg Immunol (Paris); 1992 Jun; 24(6):224-30. PubMed ID: 1379813
[TBL] [Abstract][Full Text] [Related]
11. [Tavegyl in the treatment of allergic diseases and neurovascular disorders of the nose].
Melik A
Schweiz Rundsch Med Prax; 1970 May; 59(18):676-8. PubMed ID: 4396440
[No Abstract] [Full Text] [Related]
12. [Experience in the clinical use of Tavegyl in nose diseases--judgment of effectiveness by cross-over method].
Sugiura S
Jibiinkoka; 1971 Nov; 43(11):931-42. PubMed ID: 4401875
[No Abstract] [Full Text] [Related]
13. Meclastine in hay fever.
Practitioner; 1972 Jun; 208(248):839-42. PubMed ID: 4402970
[No Abstract] [Full Text] [Related]
14. [Experimental and clinical studies of a new histamine antagonist].
Kallós P
Lakartidningen; 1969 Jun; 66():Suppl II:57+. PubMed ID: 4392857
[No Abstract] [Full Text] [Related]
15. [Clinical study of a new antihistaminic agent, Tavist].
Gyde MC
Vie Med Can Fr; 1972 Feb; 1(2):151-5. PubMed ID: 4404676
[No Abstract] [Full Text] [Related]
16. [Antihistaminic-corticoid combinations in allergy].
Basomba Riba A; García Villalmanzo I; Baguena Candela J
Rev Clin Esp; 1973 Dec; 131(6):491-500. PubMed ID: 4149906
[No Abstract] [Full Text] [Related]
17. [Experience with a new antihistaminic in dermatology. Results of a clinical double blind trial].
Eberhartinger C; Ebner H
Wien Med Wochenschr; 1969 Sep; 119(38):630-2. PubMed ID: 4390510
[No Abstract] [Full Text] [Related]
18. [Therapeutic effectiveness of a new antihistaminic, derivative of benzhydryl ether (HS 592), in various allergic diseases].
Stroescu V; Popescu IG; Dumitrescu C
Stud Cercet Med Interna; 1969; 10(4):365-9. PubMed ID: 4391855
[No Abstract] [Full Text] [Related]
19. Clinical observations on a new dihydrodibenzoxazepine (SQ 10,648) with potent antihistaminic properties.
Seals RL; Craver BN; Troop RC
Curr Ther Res Clin Exp; 1966 Feb; 8(2):35-40. PubMed ID: 4379282
[No Abstract] [Full Text] [Related]
20. [Determination of therapeutic effect of antihistaminics---clinical effect of HS 592].
Okuda M; Sekine K
Jibiinkoka; 1970 Jul; 42(7):555-7. PubMed ID: 4394032
[No Abstract] [Full Text] [Related]
[Next] [New Search]